Article info

Download PDFPDF
Concise report
Hormonal replacement therapy may reduce the risk for RA in women with early arthritis who carry HLA-DRB1 *01 and/or *04 alleles by protecting against the production of anti-CCP: results from the ESPOIR cohort
  1. Correspondence to Dr Carine Salliot, Paris Descartes University, Medicine Faculty UPRES-EA 4058 APHP, Hôpital Cochin, Service de Rhumatologie B, rue du faubourg Saint-Jacques, 75014 Paris, France; carinesalliot{at}cch.aphp.fr
View Full Text

Citation

Salliot C, Bombardier C, Saraux A, et al
Hormonal replacement therapy may reduce the risk for RA in women with early arthritis who carry HLA-DRB1 *01 and/or *04 alleles by protecting against the production of anti-CCP: results from the ESPOIR cohort

Publication history

  • Accepted August 17, 2009
  • First published September 9, 2009.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.